These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11950754)

  • 1. Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.
    Sudlow C; Sandercock P; Warlow C
    BMJ; 2002 Apr; 324(7342):917. PubMed ID: 11950754
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease.
    Pignone M; Mulrow C
    BMJ; 2002 Apr; 324(7342):917. PubMed ID: 11951911
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy for ischemic heart disease in the elderly.
    Frishman WH; Miller KP
    Geriatrics; 1988 Dec; 43 Suppl():46-56. PubMed ID: 3056785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for the primary prevention of coronary events.
    Mehta JL
    N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12239271
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin for the primary prevention of coronary events.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
    Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS
    Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ankle brachial index screening for selecting patients for antiplatelet drug therapy.
    Krantz MJ; Coronel SM; Hiatt WR
    Pharmacotherapy; 2005 Dec; 25(12):1826-8; discussion 1827-8. PubMed ID: 16305303
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Rajagopal V; Bhatt DL
    Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice. Aspirin for primary prevention of coronary events.
    Lauer MS
    N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
    [No Abstract]   [Full Text] [Related]  

  • 12. Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.
    Reilly M; FitzGerald GA
    BMJ; 2002 Jan; 324(7329):59-60. PubMed ID: 11786434
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of coronary heart disease with aspirin].
    Kübler W
    Z Kardiol; 2004; 93 Suppl 2():II33-6. PubMed ID: 15021994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and heart disease.
    Nurse Pract; 1996 Nov; 21(11):111-2. PubMed ID: 8933540
    [No Abstract]   [Full Text] [Related]  

  • 16. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and your heart: many questions, some answers.
    Harv Mens Health Watch; 2010 Dec; 15(5):1-5. PubMed ID: 21207838
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiplatelet agents and cardiovascular prevention].
    Barry S; Mercier S
    Therapie; 1997; 52(1):53-8. PubMed ID: 9183923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.